ET-traps

ET-traps is a biotech venture that aims to develop novel therapeutic intervention in a host of different diseases associated with increased endothelin-1 levels. Numerous research has shown that increased endothelin-1 levels are a critical factor in the pathophysiology of these diseases. Our technology could potentially provide a unique treatment option in several areas of unmet medical need. Visit the ET-traps website:

https://et-traps.co.uk/